Hegele, R. A. Et Al. 2020. Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement. LANCET DIABETES & ENDOCRINOLOGY , vol.8, no.1 , 50-67.

Hegele, R. A., Boren, J., Ginsberg, H. N., Arca, M., Averna, M., Binder, C. J., ... Calabresi, L.(2020). Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement. LANCET DIABETES & ENDOCRINOLOGY , vol.8, no.1, 50-67.

Hegele, Robert Et Al. "Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement," LANCET DIABETES & ENDOCRINOLOGY , vol.8, no.1, 50-67, 2020

Hegele, Robert A. Et Al. "Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement." LANCET DIABETES & ENDOCRINOLOGY , vol.8, no.1, pp.50-67, 2020

Hegele, R. A. Et Al. (2020) . "Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement." LANCET DIABETES & ENDOCRINOLOGY , vol.8, no.1, pp.50-67.

@article{article, author={Robert A. Hegele Et Al. }, title={Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement}, journal={LANCET DIABETES & ENDOCRINOLOGY}, year=2020, pages={50-67} }